# A Study of Various Treatments in Serous or p53 Abnormal Endometrial Cancer

> **NCT04159155** · PHASE2,PHASE3 · TERMINATED · sponsor: **University Health Network, Toronto** · enrollment: 11 (actual)

## Conditions studied

- Endometrial Carcinoma
- P53 Mutation
- Serous Carcinoma

## Interventions

- **RADIATION:** External Beam Radiation
- **DRUG:** Niraparib
- **RADIATION:** Vaginal high-dose rate brachytherapy
- **OTHER:** Observation - no drugs

## Key facts

- **NCT ID:** NCT04159155
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-11-17
- **Primary completion:** 2025-05-26
- **Final completion:** 2025-05-26
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Low accrual
- **Last updated:** 2025-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04159155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04159155, "A Study of Various Treatments in Serous or p53 Abnormal Endometrial Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04159155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*